z-logo
open-access-imgOpen Access
PHASE I DOSE ESCALATION TRIAL OF HuM 291, A HUMANIZED ANTI-CD3 ANTIBODY, IN LIVING DONOR KIDNEY RECIPIENTS
Author(s) -
Douglas J. Norman,
Flavio Vincenti,
Angelo de Mattos,
John M. Barry,
Daniel Levitt,
Nancy Wedel,
Susan Light
Publication year - 1999
Publication title -
transplantation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.45
H-Index - 204
eISSN - 1534-6080
pISSN - 0041-1337
DOI - 10.1097/00007890-199904150-00810
Subject(s) - medicine , chills , adverse effect , transplantation , nausea , antibody , gastroenterology , immunology , pharmacology

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here